Physician profile

Nathan Zurcher

Psychiatric/Mental Health (Nurse Practitioner) · Providence, UT

NPI 1164085676

$276.31

in general payments reported to CMS, 2019-2025

7 companies · none reported in 2025

See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$235.82

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abbvie INC. $137.15 2023-2024
Indivior INC. $56.17 2024 Sublocade
Neurocrine Biosciences, INC. $27.33 2022
Janssen Pharmaceuticals, INC $14.78 2023 Spravato
E.R. Squibb & Sons, L.L.C. $14.57 2024
Astrazeneca Pharmaceuticals LP $13.16 2021
Lundbeck LLC $13.15 2023 Rexulti

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Nathan Zurcher

$276.31

in general payments reported 2019-2025

Years
2021-2024
Top company
Abbvie INC.

https://glasscript.com/doctor/10822672/nathan-zurcher

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.